Treatment of fragile X syndrome with cannabidiol
View Patent ↗The present technology relates to a method of treating one or more behavioral symptoms of Fragile X Syndrome in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of Fragile X Syndrome are treated in the subject.
1. A method of treating a human suffering from Fragile X Syndrome comprising:
transdermally administering via a gel or cream, 250 mg or 500 mg of cannabidiol total daily to the human suffering from Fragile X Syndrome to effectively treat the Fragile X Syndrome in the human in need thereof.
2. The method of claim 1 , wherein the cannabidiol is (-)-cannabidiol.
3. The method of claim 1 , wherein the cannabidiol is formulated as a gel.
4. The method of claim 3 , wherein the cannabidiol is formulated as a permeation-enhanced gel.
5. The method of claim 1 , wherein the cannabidiol is administered in two daily doses.
6. The method of claim 1 , wherein the cannabidiol is transdermally administered on the human's upper arm and shoulder.